Why Hawkins (HWKN) Is On Investors’ Radar

Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies.

With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients.

While the share price return over the past week has been muted, Hawkins still carries a 30 day share price return of 13.88% alongside a 1 year total shareholder return of 40.62%, which indicates momentum has been building recently.

If Hawkins’ recent strength has you thinking about what else is moving, it could be a good time to scan for other opportunities using the 18 top founder-led companies

With Hawkins trading at $167.01 against an analyst price target of $188 and an intrinsic value estimate that sits higher than today’s price, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?

Preferred P/E of 42.4x: Is It Justified?

Hawkins currently trades on a P/E of 42.4x, which is high compared with both peers and the wider US Chemicals industry given the last close of $167.01.

The P/E ratio compares the share price to earnings per share, so a higher multiple usually means investors are paying more for each dollar of current earnings. For a company like Hawkins, with exposure to water treatment, industrial chemicals, and health and nutrition, that kind of premium often reflects expectations around durability of earnings and the quality of cash flows rather than rapid expansion alone.

Here, the market is assigning a much richer valuation than several benchmarks suggest. Hawkins trades at 42.4x earnings, compared with 14.1x for its peer average and 28.1x for the broader US Chemicals industry, while an estimated fair P/E of 18.3x indicates a level the market could potentially move closer to if sentiment cools or expectations reset.

Result: Price-to-earnings of 42.4x (OVERVALUED)

However, that premium could be vulnerable if expectations reset, for example, through weaker revenue or net income growth or a shift in analyst price targets.

Another View: What The DCF Model Says

While the 42.4x P/E suggests Hawkins might be pricing in a lot of optimism, the SWS DCF model points to a different conclusion. With an estimated future cash flow value of $120.87 versus the current $167.01 share price, this model flags Hawkins as overvalued on a cash flow basis. So which signal do you pay more attention to?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hawkins for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment mixed between potential rewards and flagged risks, now is the moment to look through the numbers yourself and test the story against your own expectations using the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Hawkins has sharpened your focus, do not stop here. Broader research across quality watchlists can help you spot opportunities you might otherwise miss.

• Target stability by checking out companies highlighted in the 71 resilient stocks with low risk scores that score well on resilience and risk controls.
• Hunt for quality at a reasonable price by reviewing the 51 high quality undervalued stocks built around strong fundamentals and appealing valuations.
• Seek reliable income streams by scanning the 12 dividend fortresses focused on higher yielding dividend stocks with solid profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.